Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × carotuximab × Clear all

NCT02520063 2026-02-06

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Phase 1/2 Completed

15 enrolled 18 charts

Breast Neoplasms

NCT01326481 2019-03-18

TRC105

Phase 1/2 Completed

19 enrolled 9 charts

Breast Neoplasms